Chemotherapy versus tyrosine kinase inhibitor in EGFR unselected population advanced non-small cell lung cancer still matter of debate?—An update incorporating the DELTA trial data...

Por Garassino, Marina C., Broggini, Massimo
Publicado no J Thorac Dis (2015)

Targeted therapies in small cell lung cancer: a review

Por Abidin, Aidalena Z., Garassino, Marina C., Califano, Raffaele, Harle, Amelie, Blackhall, Fiona
Publicado em 2010

The 5′UTR variant of ERCC5 fails to influence outcomes in ovarian and lung cancer patients undergoing treatment with platinum-based drugs

Por Rulli, Eliana, Guffanti, Federica, Caiola, Elisa, Ganzinelli, Monica, Damia, Giovanna, Garassino, Marina C., Piva, Sheila, Ceppi, Lorenzo, Broggini, Massimo, Marabese, Mirko
Publicado no Sci Rep (2016)

KRAS mutations affect prognosis of non-small-cell lung cancer patients treated with first-line platinum containing chemotherapy

Por Marabese, Mirko, Ganzinelli, Monica, Garassino, Marina C., Shepherd, Frances A., Piva, Sheila, Caiola, Elisa, Macerelli, Marianna, Bettini, Anna, Lauricella, Calogero, Floriani, Irene, Farina, Gabriella, Longo, Flavia, Bonomi, Lucia, Fabbri, M. Agnese, Veronese, Silvio, Marsoni, Silvia, Broggini, Massimo, Rulli, Eliana
Publicado no Oncotarget (2015)

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

Por Brahmer, Julie, Reckamp, Karen L., Baas, Paul, Crinò, Lucio, Eberhardt, Wilfried E.E., Poddubskaya, Elena, Antonia, Scott, Pluzanski, Adam, Vokes, Everett E., Holgado, Esther, Waterhouse, David, Ready, Neal, Gainor, Justin, Frontera, Osvaldo Arén, Havel, Libor, Steins, Martin, Garassino, Marina C., Aerts, Joachim G., Domine, Manuel, Paz-Ares, Luis, Reck, Martin, Baudelet, Christine, Harbison, Christopher T., Lestini, Brian, Spigel, David R.
Publicado no N Engl J Med (2015)